PGBD4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.312000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.455000E-01
Normal-vs-Stage2
4.293400E-01
Normal-vs-Stage3
3.184800E-01
Normal-vs-Stage4
3.595200E-01
Stage1-vs-Stage2
4.177700E-02
Stage1-vs-Stage3
2.826400E-02
Stage1-vs-Stage4
3.487600E-01
Stage2-vs-Stage3
1.849780E-01
Stage2-vs-Stage4
8.492600E-01
Stage3-vs-Stage4
3.076000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.358200E-01
Normal-vs-AfricanAmerican
4.217400E-01
Normal-vs-Asian
3.912000E-01
Caucasian-vs-AfricanAmerican
8.255400E-01
Caucasian-vs-Asian
4.411200E-01
AfricanAmerican-vs-Asian
6.989000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.081600E-01
Normal-vs-Female
4.635400E-01
Male-vs-Female
7.114500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.965400E-01
Normal-vs-Age(41-60Yrs)
4.443400E-01
Normal-vs-Age(61-80Yrs)
4.216600E-01
Normal-vs-Age(81-100Yrs)
4.247800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.418000E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.849600E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.582380E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.956600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.021800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.900800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.326000E-01
Normal-vs-Daily Drinker
3.814200E-01
Normal-vs-Weekly Drinker
3.973800E-01
Normal-vs-Occasional Drinker
4.125800E-01
Normal-vs-Social Drinker
5.225000E-01
Non Drinker-vs-Daily Drinker
2.634800E-01
Non Drinker-vs-Weekly Drinker
5.348200E-01
Non Drinker-vs-Occasional Drinker
6.999600E-01
Non Drinker-vs-Social Drinker
2.608200E-01
Daily Drinker-vs-Weekly Drinker
8.243600E-01
Daily Drinker-vs-Occasional Drinker
5.581200E-01
Daily Drinker-vs-Social Drinker
9.932500E-02
Weekly Drinker-vs-Occasional Drinker
8.072600E-01
Weekly Drinker-vs-Social Drinker
2.145200E-01
Occasional Drinker-vs-Social Drinker
2.277800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.414810E-01
Normal-vs-Grade 2
1.297940E-02
Normal-vs-Grade 3
6.140500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.046600E-01
Grade 1-vs-Grade 3
6.384200E-01
Grade 1-vs-Grade 4
1.414810E-01
Grade 2-vs-Grade 3
7.099200E-01
Grade 2-vs-Grade 4
1.297940E-02
Grade 3-vs-Grade 4
6.140500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.977000E-01
Normal-vs-NonDiabetic
4.338000E-01
Diabetic-vs-NonDiabetic
2.916200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.905600E-01
Normal-vs-NoPancreatitis
4.184400E-01
Pancreatitis-vs-NoPancreatitis
3.076800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.339000E-01
Normal-vs-N1
4.269000E-01
N0-vs-N1
8.547400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.525200E-01
Normal-vs-TP53-NonMutant
4.731000E-01
TP53-Mutant-vs-TP53-NonMutant
6.707800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
